← USPTO Patent Applications

COMBINATION OF ANTI-B7-H3 ANTIBODY-DRUG CONJUGATE AND ATR INHIBITOR OR ATM INHIBITOR

Application US20260091123A1 Kind: A1 Apr 02, 2026

Assignee

DAIICHI SANKYO COMPANY, LIMITED

Inventors

Len KATSUMATA, Jun HASEGAWA, Chiharu HATTORI

Abstract

In some aspects, an object of the present invention is to provide a pharmaceutical composition and a method of treatment comprising administering a specific anti-B7-H3 antibody-drug conjugate in combination with an ATR inhibitor or an ATM inhibitor. Solution: In some aspects, provided is a pharmaceutical composition and a method of treatment, comprising administering an antibody-drug conjugate, in which a drug-linker represented by the following formula: wherein A represents a connecting position to an anti-B7-H3 antibody, and the anti-B7-H3 antibody are conjugated via a thioether bond, in combination with an ATR inhibitor or an ATM inhibitor.

CPC Classifications

A61K 47/6849 A61K 31/4745 A61K 31/5377 A61K 47/545 A61K 47/65 A61K 47/68037 A61P 35/00

Filing Date

2025-10-09

Application No.

19353836